Potential effects of pomegranate polyphenols in cancer prevention and therapy

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Turrini, Eleonora ^a   Ferruzzi, Lorenzo ^a   Fimognari, Carmela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; FRUITS; RISK ASSESSMENT; UROLOGY;

ANTI-CANCER AGENTS; ANTI-PROLIFERATIVE; ANTICANCER ACTIVITIES; COMPREHENSIVE ANALYSIS; CRITICAL EVALUATION; FRUIT CONSUMPTION; POTENTIAL EFFECTS; PROSTATE SPECIFIC ANTIGEN;

DISEASES;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPHENOL; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COLON CANCER; CONCENTRATION (PARAMETERS); DOWN REGULATION; GENOTOXICITY; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; METASTASIS INHIBITION; NEOPLASM; POMEGRANATE; PROSTATE CANCER; REVIEW; SKIN CANCER; UPREGULATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; LYTHRACEAE; METABOLISM; NEOPLASMS; PATHOLOGY;

LYTHRACEAE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; POLYPHENOLS; PUNICACEAE;

EID: 84934958629     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/938475     Document Type: Review

References (147)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal, "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, " CA Cancer Journal for Clinicians, vol. 61, no. 4, pp. 212-236, 2011
2. H. Boeing, A. Bechthold, A. Bub et al., "Critical review: vegetables and fruit in the prevention of chronic diseases, " European Journal of Nutrition, vol. 51, no. 6, pp. 637-663, 2012
3. N. P. Seeram, L. S. Adams, S. M. Henning et al., "In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice, " Journal of Nutritional Biochemistry, vol. 16, no. 6, pp. 360-367, 2005
4. E. P. Lansky and R. A. Newman, "Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer, " Journal of Ethnopharmacology, vol. 109, no. 2, pp. 177-206, 2007
5. L. Gu, M. A. Kelm, J. F. Hammerstone et al., "Concentrations of proanthocyanidins in common foods and estimations of normal consumption, " Journal of Nutrition, vol. 134, no. 3, pp. 613-617, 2004
6. A. Faria and C. Calhau, "The bioactivity of pomegranate: impact on health and disease, " Critical Reviews in Food Science and Nutrition, vol. 51, no. 7, pp. 626-634, 2011
7. N. Seeram, R. Lee, M. Hardy, and D. Heber, "Rapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry, " Separation and Purification Technology, vol. 41, no. 1, pp. 49-55, 2005
8. I. F. F. Benzie and S. Wachtel-Galor, HerbalMedicine: Biomolecular and Clinical Aspects, CRC Press, Boca Raton, Fla, USA, 2nd edition, 2011
9. M. I. Gil, F. A. Tomas-Barberan, B. Hess-Pierce, D. M. Holcroft, and A. A. Kader, "Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing, " Journal of Agricultural and Food Chemistry, vol. 48, no. 10, pp. 4581-4589, 2000
10. B. Cerdá, R. Llorach, J. J. Cerón, J. C. Espń, and F. A. Tomás-Barberán, "Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice, " European Journal of Nutrition, vol. 42, no. 1, pp. 18-28, 2003
11. B. Cerdá, J. C. Espin, S. Parra, P. Martinez, and F. A. Tomás-Barberán, "The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans, " European Journal of Nutrition, vol. 43, no. 4, pp. 205-220, 2004
12. J. C. Espin, R. González-Barrio, B. Cerdá, C. López-Bote, A. I. Rey, and F. A. Tomás-Barberán, "Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans, " Journal of Agricultural and Food Chemistry, vol. 55, no. 25, pp. 10476-10485, 2007
13. M. Larrosa, F. A. Tomás-Barberán, and J. C. Esp?n, "The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using themitochondrial pathway, " Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 611-625, 2006
14. N. P. Seeram, W. J. Aronson, Y. Zhang et al., "Pomegranate ellagitannin-derivedmetabolites inhibit prostate cancer growth and localize to themouse prostate gl and , " Journal of Agricultural and Food Chemistry, vol. 55, no. 19, pp. 7732-7737, 2007
15. N. P. Seeram, R. Lee, and D. Heber, "Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatumL.) juice, " Clinica Chimica Acta, vol. 348, no. 1-2, pp. 63-68, 2004
16. S. U. Mertens-Talcott, P. Jilma-Stohlawetz, J. Rios, L. Hingorani, and H. Derendorf, "Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a st and ardized extract in healthy human volunteers, " Journal of Agricultural and Food Chemistry, vol. 54, no. 23, pp. 8956-8961, 2006
17. F. Aqil, R. Munagala, M. V. Vadhanam et al., "Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk, " Food Research International, vol. 49, no. 1, pp. 345-353, 2012
18. A. P. Kulkarni, H. S. Mahal, S. Kapoor, and S. M. Aradhya, "In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin, " Journal of Agricultural and Food Chemistry, vol. 55, no. 4, pp. 1491-1500, 2007
19. Y. Noda, T. Kaneyuki, A. Mori, and L. Packer, "Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin, " Journal ofAgricultural and Food Chemistry, vol. 50, no. 1, pp. 166-171, 2002
20. M. V. Dassprakash, R. Arun, S. K. Abraham, and K. Premkumar, "In vitro and in vivo evaluation of antioxidant and antigenotoxic potential of Punica granatum leaf extract, " Pharmaceutical Biology, vol. 50, no. 12, pp. 1523-1530, 2012
21. M. Zahin, I. Ahmad, R. C. Gupta, and F. Aqil, "Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts, " BioMed Research International, vol. 2014, Article ID 467465, 10 pages, 2014
22. F. Aqil, M. V. Vadhanam, and R. C. Gupta, "Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts, " Mutation Research-Genetic Toxicology and EnvironmentalMutagenesis, vol. 743, no. 1-2, pp. 59-66, 2012
23. J. M. Sayer, H. Yagi, A.W. Wood, A. H. Conney, and D. M. Jerina, "Extremely facile reaction between the ultimate carcinogen benzo[a]pyrene-7, 8-diol 9, 10-epoxide and ellagic acid, " Journal of the American Chemical Society, vol. 104, no. 20, pp. 5562-5564, 1982
24. C. Pohl, A. Hombach, and W. Kruis, "Chronic inflammatory bowel disease and cancer, " Hepato-Gastroenterology, vol. 47, no. 31, pp. 57-70, 2000
25. L. S. Adams, N. P. Seeram, B. B. Aggarwal, Y. Takada, D. S and , and D. Heber, "Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells, " Journal of Agricultural and Food Chemistry, vol. 54, no. 3, pp. 980-985, 2006
26. N. Banerjee, H. Kim, S. Talcott, and S. Mertens-Talcott, "Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/ AKT/mTOR, " Carcinogenesis, vol. 34, no. 12, pp. 2814-2822, 2013
27. M. Mar?n, R. M. Giner, J.-L. R?os, and M. C. Recio, "Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodiummodels of mice colitis, " Journal of Ethnopharmacology, vol. 150, no. 3, pp. 925-934, 2013
28. R. Mehta and E. P. Lansky, "Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture, " European Journal of Cancer Prevention, vol. 13, no. 4, pp. 345-348, 2004
29. Z. Dai, V. Nair, M. Khan, and H. P. Ciolino, "Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro, " Oncology Reports, vol. 24, no. 4, pp. 1087-1091, 2010
30. S. Smith, C. Salcido, M. Carlson, S. Hursting, and L. Varticovski, "Wnt-1 mammary tumors are enriched in CD44+/CD24-cells with cancer stem cell characteristics, " AACR Meeting Abstracts, vol. 2009, article 3087, 2009
31. K. M. Cadigan and R. Nusse, "Wnt signaling: a common theme in animal development, " Genes and Development, vol. 11, no. 24, pp. 3286-3305, 1997
32. N. Barker and H. Clevers, "Mining theWnt pathway for cancer therapeutics, " Nature Reviews Drug Discovery, vol. 5, no. 12, pp. 997-1014, 2006
33. N. A. H. Sadik and O. G. Shaker, "Inhibitory effect of a st and ardized pomegranate fruit extract onwnt signalling in 1, 2-dimethylhydrazine induced rat colon carcinogenesis, " Digestive Diseases and Sciences, vol. 58, no. 9, pp. 2507-2517, 2013
34. M. V. Selma, J. C. Espin, and F. A. Tomás-Barberán, "Interaction between phenolics and gut microbiota: role in human health, " Journal of Agricultural and Food Chemistry, vol. 57, no. 15, pp. 6485-6501, 2009
35. M. Sharma, L. Li, J. Celver, C. Killian, A. Kovoor, and N. P. Seeram, "Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, onWnt signaling, " Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 3965-3969, 2010
36. M. A. Nunez-Sanchez, R. Garcia-Villalba, T. Monedero-Saiz et al., "Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients, " Molecular Nutrition & Food Research, vol. 58, no. 6, pp. 1199-1211, 2014
37. M. I. Waly, A. Ali, N. Guizani, A. S. Al-Rawahi, S. A. Farooq, and M. S. Rahman, "Pomegranate (Punica granatum) peel extract efficacy as a dietary antioxidant against azoxymethane-induced colon cancer in rat, " Asian Pacific Journal of Cancer Prevention, vol. 13, no. 8, pp. 4051-4055, 2012
38. M. I. Waly, A. S. Al-Rawahi, M. Al Riyami et al., "Amelioration of azoxymethane induced-carcinogenesis by reducing oxidative stress in rat colon by natural extracts, "BMCComplementary and Alternative Medicine, vol. 14, article 60, 2014
39. A. Bishayee, D. Bhatia, R. J. Thoppil, A. S. Darvesh, E. Nevo, and E. P. Lansky, "Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidantmechanisms, " Carcinogenesis, vol. 32, no. 6, pp. 888-896, 2011
40. A. Bishayee, R. J. Thoppil, A. S. Darvesh, V. Ohanyan, J. G. Meszaros, and D. Bhatia, "Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis, " Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 178-187, 2013
41. A. Faria, R. Monteiro, I. Azevedo, and C. Calhau, "Pomegranate juice effects on cytochrome p450s expression: in vivo studies, " Journal of Medicinal Food, vol. 10, no. 4, pp. 643-649, 2007
42. D. Farkas, L. E. Oleson, Y. Zhao et al., "Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice, " Journal of Clinical Pharmacology, vol. 47, no. 3, pp. 286-294, 2007
43. Y. Takigawa and A. M. C. Brown, "Wnt signaling inliver cancer, " Current Drug Targets, vol. 9, no. 11, pp. 1013-1024, 2008
44. D. Bhatia, R. J. Thoppil, A. M and al, K. A. Samtani, A. S. Darvesh, and A. Bishayee, "Pomegranate bioactive constituents suppress cell proliferation and induce apoptosis in an experimental model of hepatocellular carcinoma: role of Wnt/-catenin signaling pathway, " Evidence-based Complementary and AlternativeMedicine, vol. 2013, Article ID 371813, 15 pages, 2013
45. F. Afaq, A. Malik, D. Syed, D. Maes, M. S. Matsui, and H. Mukhtar, "Pomegranate fruit extract modulates UV-Bmediated phosphorylation ofmitogen-Activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes, " Photochemistry and Photobiology, vol. 81, no. 1, pp. 38-45, 2005
46. A. Lisbeth, G. Noratto, L. Hingorani, S. T. Talcott, and S. U. Mertens-Talcott, "Protective effects of st and ardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts, " Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8434-8441, 2008
47. D. N. Syed, A. Malik, N. Hadi, S. Sarfaraz, F. Afaq, and H. Mukhtar, "Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes, " Photochemistry and Photobiology, vol. 82, no. 2, pp. 398-405, 2006
48. F. Afaq, N. Khan, D. N. Syed, and H. Mukhtar, "Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis, " Photochemistry and Photobiology, vol. 86, no. 6, pp. 1318-1326, 2010
49. F. Afaq, M. Saleem, C. G. Krueger, J. D. Reed, and H. Mukhtar, "Anthocyanin-And hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-B pathways and inhibits skin tumorigenesis in CD-1 mice, " International Journal of Cancer, vol. 113, no. 3, pp. 423-433, 2005
50. J. George, M. Singh, A. K. Srivastava, K. Bhui, and Y. Shukla, "Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs/NF-B and reduced cell proliferation, " Food and Chemical Toxicology, vol. 49, no. 7, pp. 1511-1520, 2011
51. L. S. Adams, Y. Zhang, N. P. Seeram, D. Heber, and S. Chen, "Pomegranate ellagitannin-derived compounds exhibit antiproferative and antiaromatase activity in breast cancer cells In vitro, " Cancer Prevention Research, vol. 3, no. 1, pp. 108-113, 2010
52. M. Larrosa, A. González-Sarras, M. T. Garca-Conesa, F. A. Tomás-Barberán, and J. C. Espn, "Urolithins, ellagic acidderived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities, " Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1611-1620, 2006
53. N. D. Kim, R. Mehta, W. Yu et al., "Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer, " Breast Cancer Research and Treatment, vol. 71, no. 3, pp. 203-217, 2002
54. D. A. Van Elswijk, U. P. Schobel, E. P. Lansky, H. Irth, and J. Van Der Greef, "Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry, " Phytochemistry, vol. 65, no. 2, pp. 233-241, 2004
55. K.-C. Jeng, C.-S. Chen, Y.-P. Fang, R. C.-W. Hou, and Y.-S. Chen, "Effect of microbial fermentation on content of statin, GABA, and polyphenols in Pu-erh tea, " Journal of Agricultural and Food Chemistry, vol. 55, no. 21, pp. 8787-8792, 2007
56. E. Sato, M. Kohno, H. Hamano, and Y. Niwano, "Increased anti-oxidative potency of garlic by spontaneous short-term fermentation, " Plant Foods for Human Nutrition, vol. 61, no. 4, pp. 157-160, 2006
57. M. Dikmen, N. Ozturk, and Y. Ozturk, "The antioxidant potency of Punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer, " Journal of Medicinal Food, vol. 14, no. 12, pp. 1638-1646, 2011
58. M. A. L. Jeune, J. Kumi-Diaka, and J. Brown, "Anticancer activities of pomegranate extracts and genistein in human breast cancer cells, " Journal of Medicinal Food, vol. 8, no. 4, pp. 469-475, 2005
59. T. Sakamoto, H. Horiguchi, E. Oguma, and F. Kayama, "Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells, " Journal of Nutritional Biochemistry, vol. 21, no. 9, pp. 856-864, 2010
60. S. Banerjee, S. Kambhampati, S. K. Banerjee, and I. Haque, "Pomegranate sensitizes Tamoxifen action in ER-positive breast cancer cells, " Journal of Cell Communication and Signaling, vol. 5, no. 4, pp. 317-324, 2011
61. A. B. Shirode, P. Kovvuru, S. V. Chittur, S. M. Henning, D. Heber, and R. Reliene, "Antiproliferative effects of pomegranate extract inMCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double str and breaks, " Molecular Carcinogenesis, vol. 53, no. 6, pp. 458-470, 2014
62. Y. Murakawa, E. Sonoda, L. J. Barber et al., "Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells, " Cancer Research, vol. 67, no. 18, pp. 8536-8543, 2007
63. B. Qiao, M. Kerr, B. Groselj et al., "Imatinib radiosensitizes bladder cancer by targeting homologous recombination, " Cancer Research, vol. 73, no. 5, pp. 1611-1620, 2013
64. B. Ladd, J. J. Ackroyd, J. K. Hicks, C. E. Canman, S. A. Flanagan, and D. S. Shewach, "Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity, " DNA Repair, vol. 12, no. 12, pp. 1114-1121, 2013
65. J. Folkman, "Angiogenesis in cancer, vascular, rheumatoid and other disease, " Nature Medicine, vol. 1, no. 1, pp. 27-31, 1995
66. M. Toi, H. B and o, C. Ramach and ran et al., "Preliminary studies on the anti-Angiogenic potential of pomegranate fractions in vitro and in vivo, " Angiogenesis, vol. 6, no. 2, pp. 121-128, 2003
67. C. J. Malemud, "Matrix metalloproteinases (MMPs) in health and disease: an overview, " Frontiers in Bioscience, vol. 11, no. 2, pp. 1696-1701, 2006
68. C. M. Overall and C. López-Ot?n, "Strategies for MMP inhibition in cancer: innovations for the post-trial era, " Nature Reviews Cancer, vol. 2, no. 9, pp. 657-672, 2002
69. I. Stamenkovic, "Matrix metalloproteinases in tumor invasion and metastasis, " Seminars in Cancer Biology, vol. 10, no. 6, pp. 415-433, 2000
70. A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian, "Matrix metalloproteinases: Biologic activity and clinical implications, " Journal of Clinical Oncology, vol. 18, no. 5, pp. 1135-1149, 2000
71. S. Ahmed, N. Wang, B. B. Hafeez, V. K. Cheruvu, and T. M. Haqqi, "Punica granatum L. extracts inhibits IL-1-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-B in human chondrocytes in vitro, " Journal of Nutrition, vol. 135, no. 9, pp. 2096-2102, 2005
72. K. S. Mix, J. A. Mengshol, U. Benbow, M. P. Vincenti, M. B. Sporn, and C. E. Brinckerhoff, "A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines, " Arthritis & Rheumatology, vol. 44, no. 5, pp. 1096-1104, 2001
73. F. Afaq, M. A. Zaid, N. Khan, M. Dreher, and H. Mukhtar, "Protective effect of pomegranate-derived products on UVBmediated damage in human reconstituted skin, " Experimental Dermatology, vol. 18, no. 6, pp. 553-561, 2009
74. S. Sreeja, T. R. Santhosh Kumar, B. S. Lakshmi, and S. Sreeja, "Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivomodels of estrogen deprivation, " Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 725-732, 2012
75. R. Siegel, J. Ma, Z. Zou, and A. Jemal, "Cancer statistics, 2014, " CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9-29, 2014
76. K. A. Klein, R. E. Reiter, J. Redula et al., "Progression of metastatic human prostate cancer to and rogen independence in immunodeficient SCID mice, " Nature Medicine, vol. 3, no. 4, pp. 402-408, 1997
77. M. Y. Hong, N. P. Seeram, and D. Heber, "Pomegranatepolyphenols down-regulate expression of and rogen-synthesizing genes in human prostate cancer cells overexpressing the and rogen receptor, " Journal of Nutritional Biochemistry, vol. 19, no. 12, pp. 848-855, 2008
78. D. S. Ming, S. Pham, S. Deb et al., "Pomegranate extracts impact the and rogen biosynthesis pathways in prostate cancer models in vitro and in vivo, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 19-28, 2014
79. M. Albrecht, W. Jiang, J. Kumi-Diaka et al., "Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells, " Journal of Medicinal Food, vol. 7, no. 3, pp. 274-283, 2004
80. K. Vermeulen, D. R. Van Bockstaele, and Z. N. Berneman, "The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, " Cell Proliferation, vol. 36, no. 3, pp. 131-149, 2003
81. A. Malik, F. Afaq, S. Sarfaraz, V. M. Adhami, D. N. Syed, and H. Mukhtar, "Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 41, pp. 14813-14818, 2005
82. L. Wang, A. Alcon, H. Yuan, J. Ho, Q.-J. Li, and M. Martins-Green, "Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells, " Integrative Biology, vol. 3, no. 7, pp. 742-754, 2011
83. Y. Wang, S. Zhang, S. Iqbal et al., "Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy, " The Prostate, vol. 74, no. 5, pp. 497-508, 2014
84. S. Fukuda and L. M. Pelus, "Survivin, a cancer target with an emerging role in normal adult tissues, " Molecular Cancer Therapeutics, vol. 5, no. 5, pp. 1087-1098, 2006
85. M. B. Rettig, D. Heber, J. An et al., "Pomegranate extract inhibits and rogen-independent prostate cancer growth through a nuclear factor-B-dependent mechanism, " Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2662-2671, 2008
86. J. Domingo-Domenech, B. Mellado, B. Ferrer et al., "Activation of nuclear factor-B in human prostate carcinogenesis and association to biochemical relapse, " British Journal of Cancer, vol. 93, no. 11, pp. 1285-1294, 2005
87. V. Fradet, L. Lessard, L. R. Begin, P. Karakiewicz, A.-M. Mes Masson, and F. Saad, "Nuclear factor-B nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer, " Clinical Cancer Research, vol. 10, no. 24, pp. 8460-8464, 2004
88. V. M. Adhami, I. A. Siddiqui, D. N. Syed, R. K. Lall, and H. Mukhtar, "Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model, " Carcinogenesis, vol. 33, no. 3, pp. 644-651, 2012
89. N. Hay, "The Akt-mTOR tango and its relevance to cancer, " Cancer Cell, vol. 8, no. 3, pp. 179-183, 2005
90. S. M. Firth and R. C. Baxter, "Cellular actions of the insulin-like growth factor binding proteins, " Endocrine Reviews, vol. 23, no. 6, pp. 824-854, 2002
91. S. Koyama, L. J. Cobb, H. H. Mehta et al., "Pomegranate extract induces apoptosis in human prostate cancer cells bymodulation of the IGF-IGFBP axis, " GrowthHormone and IGF Research, vol. 20, no. 1, pp. 55-62, 2010
92. R. Vicinanza, Y. Zhang, S. M. Henning, and D. Heber, "Pomegranate juice metabolites, ellagic acid and urolithin a, synergistically inhibit and rogen-independent prostate cancer cell growth via distinct effects on cell cycle control and apoptosis, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 247504, 12 pages, 2013
93. M. R. Sartippour, N. P. Seeram, J. Y. Rao et al., "Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo, " International Journal of Oncology, vol. 32, no. 2, pp. 475-480, 2008
94. J. R. Jackson, M. P. Seed, C. H. Kircher, D. A. Willoughby, and J. D. Winkler, "The codependence of angiogenesis and chronic inflammation, " The FASEB Journal, vol. 11, no. 6, pp. 457-465, 1997
95. B. B. Aggarwal and S. Shishodia, "Molecular targets of dietary agents for prevention and therapy of cancer, " Biochemical Pharmacology, vol. 71, no. 10, pp. 1397-1421, 2006
96. S.-T. Lee, Y.-L. Wu, L.-H. Chien, S.-T. Chen, Y.-K. Tzeng, and T.-F. Wu, "Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell, " Proteomics, vol. 12, no. 21, pp. 3251-3262, 2012
97. L. Labrecque, S. Lamy, A. Chapus et al., "Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound, " Carcinogenesis, vol. 26, no. 4, pp. 821-826, 2005
98. E.P. Lansky, W. Jiang, H. Mo et al., "Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions, " Investigational New Drugs, vol. 23, no. 1, pp. 11-20, 2005
99. K. V. Honn, R. S. Bockman, and L. J. Marnett, "Prostagl and ins and cancer: a review of tumor initiation through tumor metastasis, " Prostagl and ins, vol. 21, no. 5, pp. 833-864, 1981
100. H. Sheng, J. Shao, M. K. Washington, and R. N. DuBois, "Prostagl and in E2 increases growth and motility of colorectal carcinoma cells, " Journal of Biological Chemistry, vol. 276, no. 21, pp. 18075-18081, 2001
101. A. A. Chaudry, K. W. J. Wahle, S. McClinton, and L. E. F. Moffat, "Arachidonic acidmetabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors, " International Journal of Cancer, vol. 57, no. 2, pp. 176-180, 1994
102. E. P. Lansky, G. Harrison, P. Froom, and W. G. Jiang, "Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion acrossMatrigel, " Investigational New Drugs, vol. 23, no. 2, pp. 121-122, 2005
103. S. Seton-Rogers, "Metastasis: multitasking hyaluronic acid, " Nature Reviews Cancer, vol. 12, no. 4, p. 228, 2012
104. E. A. Turley, P. W. Noble, and L. Y.W. Bourguignon, "Signaling properties of hyaluronan receptors, " Journal of Biological Chemistry, vol. 277, no. 7, pp. 4589-4592, 2002
105. L. Wang, J. Ho, C. Glackin, and M. Martins-Green, "Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis, " Translational Oncology, vol. 5, no. 5, pp. 344-355, 2012
106. A. F. Chambers, A. C. Groom, and I. C. MacDonald, "Dissemination and growth of cancer cells in metastatic sites, " Nature Reviews Cancer, vol. 2, no. 8, pp. 563-572, 2002
107. B. A. Teicher and S. P. Fricker, "CXCL12 (SDF-1)/CXCR4 pathway in cancer, " Clinical Cancer Research, vol. 16, no. 11, pp. 2927-2931, 2010
108. L. Wang, W. Li, M. Lin et al., "Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis, " Carcinogenesis, vol. 35, no. 10, pp. 2321-2330, 2014
109. A. Rocha, L. Wang, M. Penichet, and M. Martins-Green, "Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer, " Breast Cancer Research and Treatment, vol. 136, no. 3, pp. 647-658, 2012
110. S. J. Freedl and , M. Carducci, N. Kroeger et al., "A double-blind, r and omized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy, " Cancer Prevention Research, vol. 6, no. 10, pp. 1120-1127, 2013
111. A. González-Sarras, J. A. Gimenez-Bastida, M. T. Garca-Conesa et al., "Occurrence of urolithins, gut microbiota ellagic acidmetabolites and proliferation markers expression response in the human prostate gl and upon consumption of walnuts and pomegranate juice, "Molecular Nutrition and Food Research, vol. 54, no. 3, pp. 311-322, 2010
112. N. Khan, N. Hadi, F. Afaq, D. N. Syed, M.-H. Kweon, and H. Mukhtar, "Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice, " Carcinogenesis, vol. 28, no. 1, pp. 163-173, 2007
113. N. Khan, F. Afaq, M.-H. Kweon, K. Kim, and H. Mukhtar, "Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice, " Cancer Research, vol. 67, no. 7, pp. 3475-3482, 2007
114. T. M. Yeung, S. C. G and hi, J. L. Wilding, R. Muschel, and W. F. Bodmer, "Cancer stem cells from colorectal cancer-derived cell lines, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3722-3727, 2010
115. S. G. Kasimsetty, D. Blalonska, M. K. Reddy, G. Ma, S. I. Khan, and D. Ferreira, "Colon cancer chemopreventive activities of pomegranate ellagitannins and Urolithins, " Journal of Agricultural and Food Chemistry, vol. 58, no. 4, pp. 2180-2187, 2010
116. H. Dahlawi, N. Jordan-Mahy, M. R. Clench, and C. L. LeMaitre, "Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia, "Nutrition and Cancer, vol. 64, no. 1, pp. 100-110, 2012
117. M. Bellido and P. A. W. Te Boekhorst, "JAK2 inhibition: reviewing a new therapeutical option in myeloproliferative neoplasms, " Advances in Hematology, vol. 2012, Article ID 535709, 6 pages, 2012
118. A. J. Marks, M. S. Cooper, R. J. Anderson et al., "Selective apoptotic killing of malignant hemopoietic cells by antibodytargeted delivery of an amphipathic peptide, " Cancer Research, vol. 65, no. 6, pp. 2373-2377, 2005
119. C. Fimognari, E. Turrini, P. Sestili et al., "Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo-And lympho-proliferative disorders and in hypoxic conditions, " PLoS ONE, vol. 9, no. 7, Article ID e101991, 2014
120. A. Renneville, C. Roumier, V. Biggio et al., "Cooperating gene mutations in acutemyeloid leukemia: a review of the literature, " Leukemia, vol. 22, no. 5, pp. 915-931, 2008
121. H. Dahlawi, N. Jordan-Mahy, M. Clench, G. J. McDougall, and C. L. Maitre, "Polyphenols are responsible for the proapoptotic properties of pomegranate juice on leukemia cell lines, " Food Science & Nutrition, vol. 1, no. 2, pp. 196-208, 2013
122. Y. Hagiwara, T. Kasukabe, Y. Kaneko, N. Niitsu, and J. Okabe-Kado, "Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemiaHL-60 cells, " International Journal ofHematology, vol. 92, no. 1, pp. 136-143, 2010
123. S. Kawaii and E. P. Lansky, "Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells, " Journal of Medicinal Food, vol. 7, no. 1, pp. 13-18, 2004
124. P. Fenaux, C. Chomienne, and L. Degos, "All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia, " Seminars in Hematology, vol. 38, no. 1, pp. 13-25, 2001
125. Z. Li, S. S. Percival, S. Bonard, and L. Gu, "Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects, "MolecularNutrition and Food Research, vol. 55, no. 7, pp. 1096-1103, 2011
126. K. W. Powers, S. C. Brown, V. B. Krishna, S. C. Wasdo, B. M. Moudgil, and S. M. Roberts, "Research strategies for safety evaluation of nanomaterials. Part VI. characterization of nanoscale particles for toxicological evaluation, " Toxicological Sciences, vol. 90, no. 2, pp. 296-303, 2006
127. S.-T. Lee, M.-H. Lu, L.-H. Chien, T.-F. Wu, L.-C. Huang, and G.-I. Liao, "Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis, " BMC Complementary and Alternative Medicine, vol. 13, article 364, 2013
128. S. G. Wang, M. H. Huang, J.H. Li, F. I. Lai, H. M. Lee, and Y. N. Hsu, "Punicalagin induces apoptotic and autophagic cell death in human U87MG glioma cells, " Acta Pharmacologica Sinica, vol. 34, no. 11, pp. 1411-1419, 2013
129. A. J. Pantuck, J. T. Leppert, N. Zomorodian et al., "Phase II study of pomegranate juice for menwith rising prostate-specific antigen following surgery or radiation for prostate cancer, " Clinical Cancer Research, vol. 12, no. 13, pp. 4018-4026, 2006
130. C. J. Paller, X. Ye, P. J. Wozniak et al., "A r and omized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer, " Prostate Cancer and Prostatic Diseases, vol. 16, no. 1, pp. 50-55, 2013
131. F. Stenner-Liewen, H. Liewen, R. Cathomas, C. Renner, U. Petrausch, and T. Sulser, "Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer-results of a phase IIb r and omized controlled trial, " Journal of Cancer, vol. 4, no. 7, pp. 597-605, 2013
132. S. Chrubasik-Hausmann, C. Vlachojannis, and B. Zimmermann, "Pomegranate juice and prostate cancer: importance of the characterisation of the active principle, " Phytotherapy Research, vol. 28, no. 11, pp. 1676-1678, 2014
133. C. Manach and J. L. Donovan, "Pharmacokinetics and metabolism of dietary flavonoids in humans, " Free Radical Research, vol. 38, no. 8, pp. 771-785, 2004
134. N. P. Seeram, Y. Zhang, R. McKeever et al., "Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects, " Journal of Medicinal Food, vol. 11, no. 2, pp. 390-394, 2008
135. N. P. Seeram, S. M. Henning, Y. Zhang, M. Suchard, Z. Li, and D. Heber, "Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours, " Journal of Nutrition, vol. 136, no. 10, pp. 2481-2485, 2006
136. S. J. Klempner and G. Bubley, "Complementary and alternative medicines in prostate cancer: from bench to bedside?" Oncologist, vol. 17, no. 6, pp. 830-837, 2012
137. C. Patel, P. Dadhaniya, L. Hingorani, and M. G. Soni, "Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies, " Food and Chemical Toxicology, vol. 46, no. 8, pp. 2728-2735, 2008
138. D. Heber, N. P. Seeram, H. Wyatt et al., "Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size, " Journal of Agricultural and Food Chemistry, vol. 55, no. 24, pp. 10050-10054, 2007
139. M. Aviram, M. Rosenblat, D. Gaitini et al., "Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation, " Clinical Nutrition, vol. 23, no. 3, pp. 423-433, 2004
140. C. C. Lin, Y. F. Hsu, T. C. Lin, and H. Y. Hsu, "Antioxidant and hepatoprotective effects of punicalagin and punicalin on acetaminophen-induced liver damage in rats, " Phytotherapy Research, vol. 15, no. 3, pp. 206-212, 2001
141. B. Cerdá, J. J. Cerón, F. A. Tomás-Barberán, and J. C. Espn, "Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic, " Journal ofAgricultural and Food Chemistry, vol. 51, no. 11, pp. 3493-3501, 2003
142. M. Azorn-Ortuño, C. Urbán, J. J. Cerón et al., "Safety evaluation of an oak-flavored milk powder containing ellagitannins upon oral administration in the rat, " Journal of Agricultural and Food Chemistry, vol. 56, no. 8, pp. 2857-2865, 2008
143. A. Sánchez-Lamar, G. Fonseca, J. L. Fuentes et al., "Assessment of the genotoxic risk of Punica granatum L. (Punicaceae) whole fruit extracts, " Journal of Ethnopharmacology, vol. 115, no. 3, pp. 416-422, 2007
144. European Food Safety Authority, "Compendium of botanicals that have been reported to contain toxic, addictive, psychotropic or other substances of concern, " EFSA Journal, 2009
145. P. C. Shukla, K. K. Singh, B. Yanagawa, H. Teoh, and S. Verma, "DNA damage repair and cardiovascular diseases, " Canadian Journal of Cardiology, vol. 26, pp. 13A-16A, 2010
146. A. O. Khan, "Genetics of primary glaucoma, " Current Opinion in Ophthalmology, vol. 22, no. 5, pp. 347-355, 2011
147. E. Storkebaum, A. Quaegebeur, M. Vikkula, and P. Carmeliet, "Cerebrovascular disorders: molecular insights and therapeutic opportunities, " Nature Neuroscience, vol. 14, no. 11, pp. 1390-1397, 2011